IgG4-RD

Clinical trials for IgG4-RD explained in plain language.

Never miss a new study

Get alerted when new IgG4-RD trials appear

Sign up with your email to follow new studies for IgG4-RD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Terminated 1

Experimental drug for rare inflammatory disease shows early promise but trial cut short

Disease control Stopped early

This study tested elotuzumab, a drug used for multiple myeloma, in people with active IgG4-related disease (IgG4-RD), a rare condition causing inflammation and organ damage. The trial was small (only 8 participants) and was terminated early, so it is unclear if the drug is safe o…

Matched conditions: IGG4-RD

Phase 2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control

Last updated Jun 27, 2026 09:03 UTC

IgG4-RD

Get alerted when new IgG4-RD trials appear

Experimental drug for rare inflammatory disease shows early promise but trial cut short